News

NewBiologix Licenses Xcell-Eng-HEK293 Cell Line to ReciBioPharm for Development and Manufacture of Adeno-Associated Virus (AAV) Therapeutics
Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines for advanced therapiesComplements and further expands ReciBioPharm’s AAV offeringAchieves industry-leading ...
GlobalData on MSN1d
NewBiologix licenses cell line technology to Recipharm Advanced Bio
NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide pharma companies access to ...
Morningstar2d
NewBiologix Licenses Xcell-Eng-HEK293 Cell Line to ReciBioPharm for Development and Manufacture of Adeno-Associated Virus (AAV) Therapeutics
The Xcell-Eng-HEK293 cell lines are high-value solutions for manufacturing recombinant adeno-associated viruses (rAAV) for use in C&GT. NewBiologix provides cGMP-ready, high-yield, viral particle ...
GEN - Genetic Engineering and Biotechnology News2d
Producer Cell Lines: Large-Scale Gene Therapy Hitmakers
Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already ...
The Manila Times3h
Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025
Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, today announced a late-breaking abstract ...
GEN - Genetic Engineering and Biotechnology News1d
Andelyn’s Platform Used to Manufacture Clinical Grade Viral Vector
There is a consistent need from researchers to manufacture a cGMP virus to support the advancement of gene therapies.
Fierce Biotech7d
Vertex discontinues AAV research for gene therapies
Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...